KELSEY EDWARDS: Open Payments
NPI 1922581172 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 26 payments from 13 companies in 2025. Trend: 2023 $339 · 2024 $313 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 4 | $62 |
| Organon LLC | 3 | $58 |
| Astellas Pharma US Inc | 3 | $57 |
| Radius Health, Inc. | 2 | $53 |
| Amgen Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $34 |
| MILLICENT US INC | 2 | $32 |
| Biogen, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: SLYND, Veozah, Tymlos, EVENITY, LILETTA, Lynkuet, ZURZUVAE, Mirena.
Industry payments across NY — which companies pay providers there.
